Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.91 |
---|---|
High | 9.31 |
Low | 8.69 |
Bid | 9.32 |
Offer | 9.51 |
Previous close | 9.02 |
Average volume | 562.20 |
---|---|
Shares outstanding | 114.85m |
Free float | 107.24m |
P/E (TTM) | -- |
Market cap | 1.16bn USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Announcements
- Applied Therapeutics Reports Third Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
- Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
- Applied Therapeutics to Participate in Upcoming Investor Conferences
- Applied Therapeutics Reports Second Quarter 2024 Financial Results
- Applied Therapeutics Added to Russell 3000® Index
- Applied Therapeutics Reports First Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
More ▼